Comparative study between propofol in a long-chain triglyceride and propofol in a medium/long-chain triglyceride during sedation with target-controlled infusion

Anaesthesia and Intensive Care

Volumn 33, Issue 3, 2005, Pages 351-355

  Yamakage, M ^a   Iwasaki, S ^a   Jeong, S W ^a   Ishiyama, S I ^a   Namiki, A ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anaesthetic: propofol; concentration; Emulsion: long chain triglyceride; medium chain triglyceride; Pain: injection; Sedation: bispectral index

Indexed keywords

LONG CHAIN TRIACYLGLYCEROL; MEDIUM CHAIN TRIACYLGLYCEROL; PROPOFOL;

ADULT; ARTICLE; BISPECTRAL INDEX; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG FORMULATION; DRUG INFUSION; EMULSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTENSION; INJECTION PAIN; INTRAVENOUS ANESTHESIA; RANDOMIZED CONTROLLED TRIAL; SEDATION; SPINE SURGERY; TARGET CONTROLLED INFUSION;

EID: 21344461223     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0503300301     Document Type: Article

References (19)

1. Smith I, White PF, Nathanson M, Goulson. Propofol. An update on its clinical use. Anesthesiology 1994; 81:1005-1043.
2. Bryson HM, Fulton BR, Faulds D. Propofol: an update of its use in anaesthesia and conscious sedation. Drugs 1995; 50:513-559.
3. Fulton B, Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995; 50:636-657.
4. Babl J, Doenicke A, Mönch V. New propofol LCT/MCT fat emulsions as solvent: approach to reducing pain on injection of propofol? Eur Hosp Pharm 1995; 1:15-21.
5. Doenicke AW, Roizen MF, Rau J, Kellermann W, Bahl J. Reducing pain during propofol injection: the role of the solvent. Anesth Analg 1996; 82:472-474.
6. Müller RH, Harnisch S. Physicochemical characterization of propofol-loaded emulsions and interaction with plasma proteins. Eur Hosp Pharm 2000; 6:24-31.
7. Thompson KA, Goodale DB. The recent development of propofol (DIPRIVAN). Intensive Care Med 2000; 26:S400-404.
8. Dutta S, Ebling WF. Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats. J Pharm Pharmacol 1998; 50:37-42.
9. White M, Kenny GN. Intravenous propofol anaesthesia using a computerised infusion system. Anaesthesia 1990; 45:204-209.
10. Chan K, So AP. The measurement of propofol in human blood samples by liquid chromatography. Methods Find Exp Clin Pharmacol 1990; 12:05-139.
11. Beller JP, Pottecher T, Lugnier A, Mangin P, Otteni JC. Prolonged sedation with propofol in ICU patients: recovery and blood concentration changes during periodic interruptions in infusion. Br J Anaesth 1988; 61:583-588.
12. Schnider TW, Minto CF, Shafer SL et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-1516.
13. Theilen HJ, Adam S, Albrecht MD, Ragaller M. Propofol in a medium- and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 2002; 95:923-929.
14. Doenicke AW, Roizen MF, Rau J et al. Pharmacokinetics and pharmacodynamics; of propofol in a new solvent. Anesth Analg 1997; 85:1399-1403.
15. Rau J, Roizen MF, Doenicke AW, O'Connor MF, Strohschneider U. Propofol in an emulsion of long- and medium-chain triglycerides: the effect on pain. Anesth Analg 2001; 93: 382-384.
16. Larsen B, Beerhalter U, Erdkönig R. Injection pain from propofol - MCT-LCT in children. A comparison with propofol-LCT. Anaesthesist 2001; 50:676-678.
17. Barker P Langton JA, Murphy P, Rowbotham DJ. Effect of prior administration of cold saline on pain during propofol injection. A comparison with cold propofol and propofol with lignocaine. Anaesthesia 1991; 46:1069-1070.
18. Russell D, Wilkes MP, Hunter SC et al. Manual compared with target-controlled infusion of propofol. Br J Anaesth 1995; 75: 526-562.
19. Glass PSA, Shafer SL, Reves JG. Intravenous drug delivery systems. In: Miller RD, ed. Anesthesia 5th edition. New York, Churchill Livingstone Inc., 2000; 377-411.